Guus Rimmelzwaan is Professor of Immunovirology at the Erasmus University Medical Centre in Rotterdam. He has a long standing track record of investigating immunity to influenza virus infections. “Working on the ‘Holy Grail’, the development of a universal influenza vaccine, is a major and motivating challenge for me”, he says.

FLUNIVAC aims to develop a novel influenza vaccine that protects against multiple influenza strains. Influenza, commonly known as the flu, is a viral infection of the respiratory tract. Influenza viruses cause regular epidemics of flu (seasonal flu). They occasionally cause pandemics such as the 2009 Mexican flu.